Empowering Medical Affairs Professionals in Their Critical Role in Integrated Evidence Generation Planning [0.03%]
赋能医学事务专业人员在整合型证据生成计划中的关键作用
Judith Nelissen,Angela Williams,Cerise James et al.
Judith Nelissen et al.
An integrated evidence generation plan (IEGP) can transform the effectiveness of how pharmaceutical companies demonstrate the value of new therapies. Medical Affairs professionals are uniquely positioned to lead and shape an IEGP, leveragin...
Impact of Regional Healthcare Policy Interventions on Biosimilar Use: A 10-year Evaluation of TNFα Inhibitors Utilization in Italy [0.03%]
意大利肿瘤坏死因子类似药使用10年评估:区域医疗政策干预对生物类似药使用的影响分析
Giacomo Vitturi,Luca Piccoli,Andrea Spini et al.
Giacomo Vitturi et al.
Background and objectives: Tumor neurosis factor alpha (TNFα) inhibitors are widely used for the treatment of immune-mediated inflammatory diseases. Following the patent expiration of infliximab, etanercept, and adalimum...
Medication Safety in India and Southeast Asia: A SWOT Analysis of Policies and Practices [0.03%]
印度和东南亚的药物安全问题:政策与实践的优势、劣势、机会与威胁分析
Sangeeta Sharma,Parminder Gautam,Deepika Sharma et al.
Sangeeta Sharma et al.
Medication safety is a critical component of patient care, yet fragmented regulations, under-reporting of adverse events, and resource constraints continue to pose risks in India and Southeast Asia. Addressing these challenges requires syst...
Placebo Response in Randomised Controlled Trials of Systemic Therapies for Cutaneous Lupus Erythematosus: A Systematic Review and Meta-Analysis [0.03%]
盘状红斑狼疮和亚急性皮肤型红斑狼疮系统治疗随机对照试验中的安慰剂效应:一项系统评价和荟萃分析
Stéphanie Légaré,Sherry Lin,Sarah Vahey et al.
Stéphanie Légaré et al.
Background: Lupus erythematosus is a heterogeneous autoimmune disease with manifestations ranging from skin-limited forms to severe systemic disease. Despite the high prevalence of skin symptoms among lupus participants, ...
Global Mapping of National Health Economic Evaluation Guidelines: Evidence from 40 Countries [0.03%]
40个国家卫生经济评价指南的全球分布特征分析:一项文献证据
Thu Anh Do,Tung Hoang
Thu Anh Do
Health economic evaluation (HEE) guidelines play an important role in health technology assessment (HTA) by supporting the consistent and transparent use of economic evidence in decision making. As countries continue updating their guidelin...
Application of Actor Network Theory to Evaluate Supply and Demand Strategies Used to Encourage International Biosimilar Uptake [0.03%]
应用行动者网络理论评估用于促进国际生物类似药接受度的供需策略
Chad Rieger,Judith A Dean,Gregory Merlo et al.
Chad Rieger et al.
Biosimilar medicines have the potential to reduce costs and expand patient access, yet uptake rate remains uneven world-wide. This policy review will (1) evaluate and compare biosimilar medicine uptake and policy frameworks across eight cou...
The Impact of Clinical Trial Participation on Quality of Life in Duchenne Muscular Dystrophy [0.03%]
杜氏肌营养不良症临床试验参与对生活质量的影响
Aidan W Leffler,Graham J Leffler,Marielle G Contesse
Aidan W Leffler
Background and objectives: While there has been an increase in Duchenne muscular dystrophy (DMD) clinical trials over the last couple of decades, there is still no cure. Many individuals with DMD spend much of their lives...
Animal Models for Drug Discovery in Schizophrenia: A Critical View from a Clinical Perspective [0.03%]
从临床角度对精神分裂症药物研发动物模型的批判性观点
Inga Dammann-Bawadkji,F Markus Leweke,Cathrin Rohleder
Inga Dammann-Bawadkji
Schizophrenia is a complex neuropsychiatric disorder manifesting with diverse positive and negative symptoms as well as cognitive impairments. Current antipsychotics primarily address positive symptoms and frequently cause substantial side ...
Amit Lalwani,Jon Zdon,Maaike Addicks et al.
Amit Lalwani et al.
Digital transformation is increasingly shaping how the Medical Affairs (MA) function generates insights, engages stakeholders, and demonstrates value within the pharmaceutical industry. This article examines how MA professionals can navigat...
Medical Affairs in the Age of Complexity: From Scientific Support to Strategic Enterprise Integrator [0.03%]
复杂时代下的医学事务:从科学支持到战略性企业整合者
Mussa Arvani
Mussa Arvani
Regulatory acceleration, expanded reliance on real-world evidence (RWE), and increasing integration of artificial intelligence (AI) into healthcare systems have substantially reshaped expectations placed on Medical Affairs. Accelerated and ...